ADVANCING
ORPHAN ONCOLOGY

TO IMPROVE THE LIFE OF PEOPLE
LIVING WITH CANCER
BY OFFERING BETTER TREATMENT OPTIONS

OUR STORY

Our Vision

2022-11-30 08:00:00

Our vision is to be a leader in identifying, developing and commercializing novel drugs that address unmet needs of people with rare cancer conditions.

Learn more about us:

Ascelia Pharma FDA and SPARKLE Update December 2022 (PDF)

Webcast Pressrelease December 2022

Quarterly Report Q3-2022

Q3-2022 Investor Conference Call

Ascelia Pharma Company Presentation December 2022